Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines
Forbes
Saturday, August 27, 2011 - 1:01pm
tags:
Pfizer, personalized medicine, Xalkori, lung cancer, crizotinib
4 Oversold Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Saturday, August 27, 2011 - 12:59pm
tags:
Complete Genomics, MannKind, Corcept Therapeutics, Medivation
Does Affymetrix Hit Buffett's Target?
Motley Fool
Saturday, August 27, 2011 - 12:57pm
tags:
Affymetrix
Biotech Sector Sees An Uptick As Investor Interest Returns
Forbes
Saturday, August 27, 2011 - 12:56pm
tags:
Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
Yahoo/GlobeNewswire
Saturday, August 27, 2011 - 12:55pm
tags:
StemCells
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Yahoo/MarketWire
Saturday, August 27, 2011 - 12:54pm
tags:
Pluristem, Fibrocell Science
Cipla eyes alliances to grow in emerging markets
Fierce Pharma
Friday, August 26, 2011 - 11:36am
tags:
emerging markets, Cipla
Warner Chilcott Stock Hits New 52-Week Low (WCRX)
TheStreet.com
Friday, August 26, 2011 - 11:34am
tags:
Warner Chilcott
The Long Term Bullish Case for Pharma
Forbes
Friday, August 26, 2011 - 11:33am
tags:
pharma industry
J&J's XR pain drug gets FDA nod
Fierce Biotech
Friday, August 26, 2011 - 10:30am
tags:
FDA, Nucynta, JNJ, painkillers
How A Pharmaceutical Giant Is Battling Malnutrition On The Ground In Haiti
Fast Company
Friday, August 26, 2011 - 9:26am
tags:
Abbott Laboratories, malnutrition, Haiti
Baxter to Acquire Baxa Corp
Contract Pharma
Friday, August 26, 2011 - 9:19am
tags:
Baxa, Baxter, M&A, drug delivery
Biosimilars: physicians cite concerns over supporting data
Pharma Times, UK
Friday, August 26, 2011 - 9:18am
tags:
biosimilars, physicians
6 Healthcare Stocks Primed For A Rebound
Seeking Alpha
Friday, August 26, 2011 - 9:16am
tags:
Apricus Biosciences, CytRx, Geron, Dendreon, SIGA technologies, ImmunoCellular
Teva, Cephalon Ask European Union Regulators to Approve Deal
Bloomberg
Friday, August 26, 2011 - 9:14am
tags:
Teva Pharmaceuticals, Cephalon, Europe, M&A
New Jersey's Par Pharmaceutical to Pay $154M to Settle Medicaid Fraud Allegations
Becker's ASC Review
Thursday, August 25, 2011 - 9:45pm
tags:
Medicare fraud, Par Pharmaceutical
Twenty Seconds Pit Glaxo Against Pfizer in India’s Drug Market
Bloomberg
Thursday, August 25, 2011 - 9:38pm
tags:
GSK, Pfizer, India, drug reps
Can Jazz Pharmaceuticals Play Through Its Recent Volatility?
Investors.com
Thursday, August 25, 2011 - 3:45pm
tags:
Jazz Pharmaceuticals
Buying Into a Hot Hepatitis C Drug Market
Minyanville
Thursday, August 25, 2011 - 3:44pm
tags:
hepatitis C, Pharmasset, Vertex, Merck, Achillion, Indenix, Inhibitex, INX-189, Incivek, Victrelis
Revs Rise at Immunomedics in Q4
Yahoo/Zacks.com
Thursday, August 25, 2011 - 3:41pm
tags:
earnings, Immunomedics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.